The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices slipping amid concerns over weak trade data from China. For investors looking beyond established names, penny stocks offer intriguing opportunities, particularly when they showcase financial resilience. Although the term "penny stocks" might seem outdated, these smaller or newer companies can still provide potential for growth and affordability in today's market landscape.
Top 10 Penny Stocks In The United Kingdom
| Name | Share Price | Market Cap | Rewards & Risks |
| Foresight Group Holdings (LSE:FSG) | £4.62 | £517.24M | ✅ 4 ⚠️ 0 View Analysis > |
| Warpaint London (AIM:W7L) | £2.73 | £220.55M | ✅ 5 ⚠️ 2 View Analysis > |
| FDM Group (Holdings) (LSE:FDM) | £1.232 | £134.68M | ✅ 2 ⚠️ 4 View Analysis > |
| Van Elle Holdings (AIM:VANL) | £0.405 | £43.82M | ✅ 4 ⚠️ 3 View Analysis > |
| Polar Capital Holdings (AIM:POLR) | £4.505 | £434.3M | ✅ 4 ⚠️ 1 View Analysis > |
| RWS Holdings (AIM:RWS) | £0.913 | £337.61M | ✅ 5 ⚠️ 2 View Analysis > |
| Alumasc Group (AIM:ALU) | £3.05 | £109.68M | ✅ 4 ⚠️ 2 View Analysis > |
| Begbies Traynor Group (AIM:BEG) | £1.17 | £186.24M | ✅ 4 ⚠️ 3 View Analysis > |
| Next 15 Group (AIM:NFG) | £2.69 | £271.49M | ✅ 3 ⚠️ 3 View Analysis > |
| Braemar (LSE:BMS) | £2.42 | £73.73M | ✅ 3 ⚠️ 4 View Analysis > |
Click here to see the full list of 298 stocks from our UK Penny Stocks screener.
Let's uncover some gems from our specialized screener.
Futura Medical (AIM:FUM)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Futura Medical plc researches, develops, and commercializes pharmaceutical and healthcare products for sexual health, with a market cap of £30.49 million.
Operations: The company generates revenue primarily from the development and commercialization of MED3000, amounting to £13.93 million.
Market Cap: £30.49M
Futura Medical has recently achieved profitability, driven by the commercialization of its MED3000 product, generating £13.93 million in revenue. The company is debt-free with stable weekly volatility but faces a highly volatile share price over the past three months. A seasoned management team with an average tenure of 8.8 years contrasts with a less experienced board averaging 2.7 years. Recent leadership changes include appointing Alex Duggan as Interim CEO, bringing extensive experience from Alliance Pharmaceuticals, where he significantly grew their Consumer Healthcare business and played a key role in its successful sale at a substantial premium.
- Click here and access our complete financial health analysis report to understand the dynamics of Futura Medical.
- Evaluate Futura Medical's prospects by accessing our earnings growth report.
Likewise Group (AIM:LIKE)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Likewise Group Plc, with a market cap of £68.54 million, wholesales and distributes floorcoverings, rugs, and matting products for domestic and commercial flooring markets in the United Kingdom and Rest of Europe.
Operations: The company's revenue is primarily generated from its textile manufacturing segment, which accounts for £149.79 million.
Market Cap: £68.54M
Likewise Group has shown resilience in the penny stock landscape, with recent earnings indicating a shift to profitability for the half year ended June 2025. Sales increased to £77.95 million from £70.75 million, and net income turned positive at £0.23 million, reflecting improved operational gearing and market share gains despite a challenging trading environment. The company completed a follow-on equity offering of £1.38 million to support expansion efforts in logistics and processing capacity, particularly in Glasgow and Derby. However, challenges remain with low return on equity at 2% and interest coverage below optimal levels at 1.4x EBIT.
- Jump into the full analysis health report here for a deeper understanding of Likewise Group.
- Learn about Likewise Group's future growth trajectory here.
Oberon Investments Group (OFEX:OBE)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Oberon Investments Group Plc operates in the United Kingdom, focusing on arranging investment deals and providing financial planning services, with a market cap of £31.99 million.
Operations: The company generates revenue primarily from its brokerage activities, amounting to £9.36 million.
Market Cap: £31.99M
Oberon Investments Group faces challenges typical of penny stocks, with a net loss of £4.14 million for the year ended March 2025 and negative return on equity. Despite this, the company has more cash than debt, providing some financial stability. Recent management changes include appointing Barry Smead as Head of Investment Management, bringing extensive industry expertise aimed at strategic growth and operational efficiency. Oberon's focus on bespoke investment services aligns with market demand for flexible strategies amidst commoditized offerings. However, its short cash runway underlines the need for careful cash flow management to sustain operations and future growth initiatives.
- Click here to discover the nuances of Oberon Investments Group with our detailed analytical financial health report.
- Understand Oberon Investments Group's track record by examining our performance history report.
Key Takeaways
- Gain an insight into the universe of 298 UK Penny Stocks by clicking here.
- Ready For A Different Approach? We've found 18 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Oberon Investments Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com